Inventor profile of:

Elias GEORGES

City:

Laval

Country:

Canada

Published Applications:

27

Last publication date:

2011-01-27

Top Assignees for applications by Elias GEORGES

The entities that hold a legal rights for patent applications filed by inventor GEORGES Elias:

Recent patent applications by GEORGES Elias

Elias GEORGES from Laval, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-01-27
US20110020370A1
Chemistry; metallurgy

SLC7A5 DIRECTED DIAGNOSTICS AND THERAPEUTICS FOR NEOPLASTIC DISEASE

#2 | 2010-10-14
US20100260667A1
Human necessities

Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease

#3 | 2009-10-08
US20090253138A1
Chemistry; metallurgy

KIF20A DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#4 | 2009-09-17
US20090233295A1
Physics

TRIM59 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#5 | 2009-09-17
US20090233294A1
Physics

UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#6 | 2009-09-17
US20090233293A1
Physics

TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#7 | 2009-06-23
US10736889
-

Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

#8 | 2009-06-18
US20090155790A1
Chemistry; metallurgy

CRAB-PII DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#9 | 2009-03-12
US20090069549A1
Chemistry; metallurgy

Protein Extraction buffer, a kit comprising it and method of its use

#10 | 2009-03-12
US20090068670A1
Physics

STRATIFIN DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#11 | 2009-03-12
US20090068669A1
Physics

SLC9A3R1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#12 | 2009-01-01
US20090004102A1
Physics

HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease

#13 | 2008-01-10
US20080009068A1
Chemistry; metallurgy

Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction

#14 | 2007-10-18
US20070243548A1
Chemistry; metallurgy

Calumenin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance

#15 | 2007-06-14
US20070134687A1
Chemistry; metallurgy

Focused microarray and methods of diagnosing cancer

#16 | 2007-06-05
US10737350
-

HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease

#17 | 2007-05-31
US20070122856A1
Physics

Tissue diagnostics for ovarian cancer

#18 | 2007-05-31
US20070122830A1
Chemistry; metallurgy

Prohibitin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance

#19 | 2007-05-31
US20070122414A1
Human necessities

Surface marker-directed cancer therapeutics

#20 | 2007-05-17
US20070111244A1
Physics

Tissue diagnostics for breast cancer

#21 | 2007-04-05
US20070077583A1
Physics

Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance

#22 | 2007-02-13
US10010310
-

Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction

#23 | 2006-12-07
US20060275810A1
Physics

Focused microarray and methods of diagnosing chemotherapeutic drug resistance in a cancer cell

#24 | 2006-08-24
US20060188507A1
Chemistry; metallurgy

Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors

#25 | 2006-01-19
US20060014225A1
Human necessities

Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

#26 | 2005-02-03
US20050026231A1
Physics

Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease

#27 | 2005-01-13
US20050009119A1
Physics

Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

InventorID:

3331797 ⎘